AXGN Stock Analysis: Buy, Sell, or Hold?
AXGN - Axogen, Inc. Common Stock
$45.89
1.87 (4.25%)
▲
5d:
+3.15%
30d:
+16.29%
90d:
+36.66%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 04, 2026
30d
Get Alerted When AXGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AXGN is fairly valued with market pricing in 3.9% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: AXGN is fairly valued with market pricing in 3.9% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$35.46
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$22.02
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AXGN is currently trading at $45.89, which is considered extended relative to its 30-day fair value range of $40.73 to $44.84. From a valuation perspective, the stock is trading at a premium (Forward PE: 63.0) compared to its historical average (56.1). At these levels, the market is pricing in 3.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, AXGN is in a strong uptrend. The price is approaching resistance at $46.95. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.2% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $50.78 (+10.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AXGN is in a strong uptrend. The price is approaching resistance at $46.95. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.2% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $50.78 (+10.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$40.73 -
$44.84
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
54.3%
Protect Your Profits
Holding AXGN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.2%)
- BULLISH: Trading below Wall St target ($50.78)
- NEUTRAL: Market pricing in 3.9% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$40.73 -
$44.84
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$41.35
Resistance Level
$46.95
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
63.01
Wall Street Target
$50.78
(+10.7%)
Revenue Growth (YoY)
26.6%
Profit Margin
-13.2%
Valuation Premium vs History
+3.9% premium
PE vs Historical
63.0 vs 56.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.9%
(market-implied from PE analysis)
1-Year Target
$47.68
(+4%)
2-Year Target
$49.54
(+8%)
3-Year Target
$51.47
(+12%)
3-Yr Target (if PE normalizes)
(PE: 63→56)
PE COMPRESSION
$45.83
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 63.0, Growth: 49.1%)
$151.98
(+231%)
Base:
(SPY PE: 21.8, Growth: 49.1%)
$52.53
(+15%)
Bear:
(PE: 18.5, Growth: 49.1%)
$44.65
(-3%)
Share & Embed Analysis
Last updated: July 03, 2026 8:28 PM ET
Data refreshes hourly during market hours. Next update: 9:28 PM
Data refreshes hourly during market hours. Next update: 9:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AXGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Erick Wayne Devinney
SELL
5221 shares
2026-03-16
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 65 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 65 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 65 BUY |
Advanced AXGN Option Strategies
Professional options setups generated by AI based on today's AXGN price and gamma walls.
